|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,328.00 JPY | -1.23% |
|
+1.93% | +34.41% |
| 10-01 | Tranche Update on EXEO Group, Inc.'s Equity Buyback Plan announced on May 9, 2025. | CI |
| 09-18 | Procurri Corp. to Delist on Sept. 22 | MT |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.89 | 5.16 | 3.65 | 3.58 | 4.3 | |||||
Return on Total Capital | 6.92 | 7.25 | 5.05 | 4.98 | 6.05 | |||||
Return On Equity % | 8.7 | 9.54 | 7.48 | 6.5 | 8.34 | |||||
Return on Common Equity | 8.75 | 9.42 | 7.33 | 6.51 | 8.47 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 13.23 | 14.18 | 13.04 | 14.52 | 14.98 | |||||
SG&A Margin | 6.84 | 7.05 | 7.85 | 8.96 | 8.65 | |||||
EBITDA Margin % | 7.9 | 8.7 | 7.15 | 7.66 | 8.49 | |||||
EBITA Margin % | 6.71 | 7.45 | 5.76 | 6.01 | 6.79 | |||||
EBIT Margin % | 6.39 | 7.12 | 5.19 | 5.46 | 6.33 | |||||
Income From Continuing Operations Margin % | 4.24 | 4.78 | 3.66 | 3.32 | 4.01 | |||||
Net Income Margin % | 4.22 | 4.67 | 3.54 | 3.27 | 4 | |||||
Net Avail. For Common Margin % | 4.22 | 4.67 | 3.54 | 3.27 | 4 | |||||
Normalized Net Income Margin | 4.22 | 4.71 | 3.24 | 3.7 | 4.09 | |||||
Levered Free Cash Flow Margin | -0.75 | 0.22 | -1.45 | 4.03 | -1.55 | |||||
Unlevered Free Cash Flow Margin | -0.73 | 0.25 | -1.39 | 4.11 | -1.46 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.22 | 1.16 | 1.13 | 1.05 | 1.09 | |||||
Fixed Assets Turnover | 5.19 | 4.95 | 4.78 | 4.36 | 4.45 | |||||
Receivables Turnover (Average Receivables) | 3.09 | 2.82 | 2.79 | 2.62 | 2.61 | |||||
Inventory Turnover (Average Inventory) | 11.56 | 11.38 | 10.91 | 9.78 | 10.26 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.92 | 2.07 | 2.22 | 1.96 | 1.88 | |||||
Quick Ratio | 1.59 | 1.73 | 1.79 | 1.6 | 1.54 | |||||
Operating Cash Flow to Current Liabilities | 0.04 | 0.17 | 0.03 | 0.24 | 0.03 | |||||
Days Sales Outstanding (Average Receivables) | 117.96 | 129.52 | 130.87 | 139.47 | 140 | |||||
Days Outstanding Inventory (Average Inventory) | 31.59 | 32.09 | 33.46 | 37.41 | 35.56 | |||||
Average Days Payable Outstanding | 49.4 | 51.38 | 47.69 | 51.8 | 49.69 | |||||
Cash Conversion Cycle (Average Days) | 100.15 | 110.22 | 116.65 | 125.08 | 125.88 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 19.5 | 25.65 | 36.49 | 32.09 | 39.53 | |||||
Total Debt / Total Capital | 16.32 | 20.41 | 26.74 | 24.29 | 28.33 | |||||
LT Debt/Equity | 9.29 | 15.63 | 27.16 | 19.81 | 23.58 | |||||
Long-Term Debt / Total Capital | 7.77 | 12.44 | 19.9 | 14.99 | 16.9 | |||||
Total Liabilities / Total Assets | 41.23 | 42.67 | 46.72 | 46.07 | 49.14 | |||||
EBIT / Interest Expense | 247.46 | 187.53 | 50.86 | 42.08 | 40.44 | |||||
EBITDA / Interest Expense | 305.93 | 228.98 | 70.08 | 59 | 54.27 | |||||
(EBITDA - Capex) / Interest Expense | 246.19 | 149.56 | 52.33 | 37.24 | 39.26 | |||||
Total Debt / EBITDA | 1.24 | 1.52 | 2.51 | 2.18 | 2.27 | |||||
Net Debt / EBITDA | 0.28 | 0.45 | 1.35 | 1.15 | 1.57 | |||||
Total Debt / (EBITDA - Capex) | 1.55 | 2.33 | 3.36 | 3.45 | 3.13 | |||||
Net Debt / (EBITDA - Capex) | 0.35 | 0.68 | 1.81 | 1.82 | 2.16 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 9.3 | 3.75 | 5.51 | -2.15 | 9.24 | |||||
Gross Profit, 1 Yr. Growth % | 11.03 | 11.15 | -2.95 | 8.95 | 12.7 | |||||
EBITDA, 1 Yr. Growth % | 14.45 | 14.3 | -13.34 | 4.85 | 21.18 | |||||
EBITA, 1 Yr. Growth % | 16.32 | 15.19 | -18.47 | 2.02 | 23.48 | |||||
EBIT, 1 Yr. Growth % | 17.76 | 15.72 | -23.19 | 3.02 | 26.62 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 55.4 | 16.81 | -19.06 | -11.37 | 32.1 | |||||
Net Income, 1 Yr. Growth % | 55.05 | 14.77 | -19.93 | -9.78 | 33.89 | |||||
Normalized Net Income, 1 Yr. Growth % | 23.16 | 15.91 | -27.45 | 11.84 | 20.62 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 55.61 | 15.4 | -18.19 | -7.54 | 36.09 | |||||
Accounts Receivable, 1 Yr. Growth % | 23.24 | 6.35 | 6.85 | 1.31 | 18.48 | |||||
Inventory, 1 Yr. Growth % | 2.4 | 6.03 | 16.63 | -0.84 | 8.04 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.29 | 11.93 | 6.88 | 7.61 | 6.69 | |||||
Total Assets, 1 Yr. Growth % | 10.49 | 8.96 | 7.9 | 2.37 | 8.6 | |||||
Tangible Book Value, 1 Yr. Growth % | 8.56 | 5.1 | -3.3 | 3.67 | 1.9 | |||||
Common Equity, 1 Yr. Growth % | 7.18 | 6.17 | -0.06 | 3.25 | 2.54 | |||||
Cash From Operations, 1 Yr. Growth % | -63.58 | 319.08 | -79.24 | 664.22 | -83.67 | |||||
Capital Expenditures, 1 Yr. Growth % | -30.35 | 103.03 | -36.74 | 52.68 | -9.1 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -164.36 | -131.01 | -784.1 | -371.84 | -142.1 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -161.77 | -135.06 | -691.35 | -390.04 | -138.68 | |||||
Dividend Per Share, 1 Yr. Growth % | 2.5 | 14.63 | 8.51 | 17.65 | 5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 16.32 | 6.49 | 4.63 | 1.61 | 3.39 | |||||
Gross Profit, 2 Yr. CAGR % | 14.04 | 11.09 | 3.86 | 2.83 | 10.81 | |||||
EBITDA, 2 Yr. CAGR % | 9.67 | 14.37 | -0.47 | -4.68 | 12.71 | |||||
EBITA, 2 Yr. CAGR % | 8.13 | 15.76 | -3.09 | -8.8 | 12.24 | |||||
EBIT, 2 Yr. CAGR % | 7.46 | 16.73 | -5.72 | -11.04 | 14.21 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -22.33 | 34.73 | -2.77 | -15.3 | 8.21 | |||||
Net Income, 2 Yr. CAGR % | -22.44 | 33.4 | -4.13 | -15.01 | 9.9 | |||||
Normalized Net Income, 2 Yr. CAGR % | 8.26 | 19.48 | -8.3 | -9.92 | 16.15 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -25.3 | 34.01 | -2.84 | -13.03 | 12.18 | |||||
Accounts Receivable, 2 Yr. CAGR % | 14.44 | 14.48 | 6.6 | 4.05 | 9.56 | |||||
Inventory, 2 Yr. CAGR % | 6.51 | 4.2 | 11.21 | 7.54 | 3.5 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.58 | 8.56 | 9.38 | 7.24 | 7.15 | |||||
Total Assets, 2 Yr. CAGR % | 8.64 | 9.72 | 8.43 | 5.1 | 5.44 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.13 | 6.82 | 0.82 | 0.13 | 2.78 | |||||
Common Equity, 2 Yr. CAGR % | 4.02 | 6.67 | 3.01 | 1.58 | 2.89 | |||||
Cash From Operations, 2 Yr. CAGR % | -29.76 | 23.55 | -6.72 | 25.97 | 11.71 | |||||
Capital Expenditures, 2 Yr. CAGR % | 79.07 | 18.92 | 13.33 | -1.72 | 17.81 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -40.79 | -55.32 | 45.66 | 331.24 | 6.98 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -41.36 | -53.47 | 43.98 | 314.15 | 5.91 | |||||
Dividend Per Share, 2 Yr. CAGR % | 8.23 | 8.4 | 11.53 | 12.99 | 11.14 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 22.4 | 11.97 | 6.16 | 2.32 | 4.09 | |||||
Gross Profit, 3 Yr. CAGR % | 20.5 | 13.07 | 6.2 | 5.53 | 6.02 | |||||
EBITDA, 3 Yr. CAGR % | 15.58 | 11.19 | 4.27 | 1.27 | 3.26 | |||||
EBITA, 3 Yr. CAGR % | 13.89 | 10.43 | 2.99 | -1.41 | 0.9 | |||||
EBIT, 3 Yr. CAGR % | 12.6 | 10.14 | 1.53 | -2.89 | 0.07 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 10.45 | -11.02 | 13.68 | -5.72 | -1.77 | |||||
Net Income, 3 Yr. CAGR % | 10.37 | -11.62 | 12.53 | -6.06 | -1.11 | |||||
Normalized Net Income, 3 Yr. CAGR % | 13.65 | 10.75 | 1.17 | -2.02 | -0.71 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 4.77 | -13.64 | 13.68 | -4.43 | 0.97 | |||||
Accounts Receivable, 3 Yr. CAGR % | 30.44 | 11.68 | 11.88 | 4.81 | 8.65 | |||||
Inventory, 3 Yr. CAGR % | 16.41 | 6.35 | 8.19 | 7.04 | 7.71 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 21.85 | 9.01 | 8 | 8.78 | 7.06 | |||||
Total Assets, 3 Yr. CAGR % | 23.08 | 8.75 | 9.11 | 6.37 | 6.25 | |||||
Tangible Book Value, 3 Yr. CAGR % | 17.05 | 5.12 | 3.33 | 1.76 | 0.71 | |||||
Common Equity, 3 Yr. CAGR % | 17.59 | 4.73 | 4.38 | 3.09 | 1.9 | |||||
Cash From Operations, 3 Yr. CAGR % | -36.66 | 27.4 | -31.82 | 88.05 | -36.25 | |||||
Capital Expenditures, 3 Yr. CAGR % | 40.12 | 86.73 | -3.64 | 25.17 | -4.24 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -38.39 | -52.27 | 10.94 | 79.33 | 98.57 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -38.86 | -50.6 | 8.59 | 81.84 | 87.9 | |||||
Dividend Per Share, 3 Yr. CAGR % | 17.93 | 10.33 | 8.44 | 13.53 | 10.26 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 14.81 | 14.76 | 14.95 | 7.7 | 5.04 | |||||
Gross Profit, 5 Yr. CAGR % | 16.21 | 16.99 | 13.55 | 8.85 | 8.02 | |||||
EBITDA, 5 Yr. CAGR % | 14.71 | 15.51 | 8.87 | 4.55 | 7.57 | |||||
EBITA, 5 Yr. CAGR % | 14.06 | 15.13 | 6.77 | 2.3 | 6.6 | |||||
EBIT, 5 Yr. CAGR % | 14.2 | 15.09 | 4.88 | 1.12 | 6.43 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 14.76 | 15.65 | 4.96 | -12.76 | 11.46 | |||||
Net Income, 5 Yr. CAGR % | 14.7 | 15.03 | 4.32 | -12.99 | 11.47 | |||||
Normalized Net Income, 5 Yr. CAGR % | 16.12 | 15.77 | 4.3 | 1.97 | 6.92 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 11.56 | 11.57 | 1.66 | -13.4 | 13.08 | |||||
Accounts Receivable, 5 Yr. CAGR % | 17.06 | 17.76 | 20.32 | 8.56 | 10.95 | |||||
Inventory, 5 Yr. CAGR % | 15.15 | 13.84 | 14.3 | 6.83 | 6.29 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13.64 | 15.4 | 16.7 | 8.3 | 7.66 | |||||
Total Assets, 5 Yr. CAGR % | 15.58 | 17.08 | 17 | 7.27 | 7.63 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.79 | 13.53 | 10.26 | 3.09 | 3.11 | |||||
Common Equity, 5 Yr. CAGR % | 13.62 | 13.94 | 11.52 | 3.46 | 3.78 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.18 | 11.24 | -26.05 | 26.83 | -16.93 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.32 | 25.52 | 28.72 | 44.45 | 4.42 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -8.63 | -24.29 | -13.08 | 15.12 | 9.34 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -8.93 | -22.84 | -13.88 | 15.64 | 7.51 | |||||
Dividend Per Share, 5 Yr. CAGR % | 16.63 | 15.36 | 15.33 | 11.38 | 9.51 |
- Stock Market
- Equities
- 1951 Stock
- Financials EXEO Group, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















